1. Market Research
  2. > Biotechnology Market Trends
  3. > Biological Therapy

Biological Therapy Industry: Top Market Reports

  • Currently 5/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
1 vote

Global Biological Therapy Industry

The world biologics industry was worth almost $150 billion in 2010, according to research from BCC Research. The market is expected to record yearly growth of around 10% to reach almost $240 billion by 2015.

Market growth is fuelled by interest in biosimilars, the need to elaborate a superior drug pipeline, a move toward cost-reducing manufacturing technologies and appealing targets against challenging diseases.

Key Market Segments

The global gene therapy market is benefiting from increasing interest in the development of disease treatment. RNCOS notes that this market holds strong development potential as progress in the field of gene therapy facilitates research into the pathogenesis of diseases. This involves a move from research laboratories to clinical trials, which leads to greater potential for the biotechnology sector. Gene therapy market expansion is expected to be very strong over the coming years, fuelled by interest from biopharma companies focused on the area. Companies are expected to elaborate therapies for disease through on-site research and grow acquired therapies into commercial forms.

Gene therapy will prove vital to the medical industry to provide a disease-specific approach to developing treatments. The therapeutic applications of gene therapy are expanding to encompass areas like acquired diseases, including immunodeficiency syndromes. Growth is strong in the US, the EU, China, Japan and Canada. Cancer treatment is expected to represent the fastest-growing segment, followed by infectious diseases such as AIDS.

The global RNA Interference (RNAi) industry is expected to record 28% yearly growth for the five-year period ending 2015, reports RNCOS. Market growth will be fuelled by greater use of the expertise for functional genomics research, necessary for target validation, drug discovery and drug development. 

The worldwide market for cancer therapiesis expected to reach $225 billion by 2017, according to research from Global Industry Analysts. Market expansion will be fuelled by increasing numbers of cancer patients, adoption of new drugs and growing existing drugs. Market growth will also be driven by greater adoption of high-priced biologic therapies in cancer treatment. Medical treatment of cancer includes therapies such as chemotherapy, radiotherapy and gene therapy. The majority of cancer therapies are elaborated using hormones and cytokines, colony stimulating factors, monoclonal antibodies oncolytic viruses, cancer vaccines, antisense oligonucleotides and other approaches.

Leading companies in the sector include Takeda Pharmaceutical Company, GlaxoSmithKline, Eli Lilly, Amgen, Hoffmann-La Roche, Janssen Biotech, Sanofi-Aventis, AstraZeneca, Celgene Corporation, Novartis, Genentech and Bristol-Myers Squibb.

Regional Market Share

The US stem cell market is expected to record yearly growth of 45% between 2011 and 2013, reports RNCOS. The market has recorded strong growth over the past few years with massive investment despite the economic recession. Stem cell technologies and products are giving rise to breakthroughs in the treatment of diseases.

Read more »


You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+33 4 37 65 17 06

1-10 of about 1400 reports

Global Biological Therapy Industry - Forecast

  • September 2017
    86 pages
  • Biological Ther...  

  • World  

View report >

Biological Therapy Industry in the US and the Netherlands

  • September 2017
    19 pages
  • Biological Ther...  


  • United States  


View report >

Biological Therapy Industry in Europe

  • August 2017
    15 pages
  • Biological Ther...  

  • Europe  

View report >

Biological Therapy Industry in Germany

  • March 2016
    14 pages
  • Biological Ther...  

  • Germany  

View report >

Biological Therapy Industry in the UK

  • April 2017
    10 pages
  • Biological Ther...  


  • United Kingdom  

View report >

Biological Therapy Industry in China

  • September 2017
    11 pages
  • Biological Ther...  

  • China  

View report >

Biological Therapy Industry in the Netherlands

  • April 2017
    12 pages
  • Biological Ther...  

  • Netherlands  

View report >

Biological Therapy Industry in Australia and the US

  • March 2017
    12 pages
  • Biological Ther...  


  • Australia  

    United States  

View report >

Search in Biological Therapy Industry (About 1400 reports)
Parent industry: Biotechnology
Related industries: Biomaterial, Biopharmaceutical, Genetically Modified Organism, Genomics

About 900 reports

Purchase Reports From Reputable Market Research Publishers
(From € 200 - € 9996)

Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis

  • € 9996
  • Industry report
  • May 2016
  • by GlobalData

Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis Summary GlobalData estimates that the total IO market will be worth approximately $14 billion in 2019, rising to $34 billion ...

Opportunityanalyzer: Growth Hormone Deficiency - Opport ...

May 2017 € 9995

Flat-rate Access To R&d Database & Reports From La Meri ...

November 2016 € 7700

Pharmafocus: Visual Analysis Of Immuno-oncology Develop ...

August 2017 € 7268

Biologics Outsourcing Global Market - Forecast To 2025

August 2017 € 6545

Frontier Pharma: Cancer Immunotherapies - First-in-clas ...

September 2017 € 6359

Frontier Pharma: Asthma Therapeutics - Cytokine And Kin ...

November 2016 € 6359

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediat ...

August 2016 € 6359

Stem Cell Assay Market By Type, Kit, Product, Applicati ...

October 2016 € 5650

Stem Cells Market - Global Industry Analysis, Size, Sha ...

September 2017 € 5268

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.